Trial intelligence / Profile preview

Tiscover vs AS210 in Chronic Venous Ulcers

NCT02360358Phase 2Terminated

Start
Aug 2012
Primary completion
Dec 2015
Modality
Implantable Devices, Implantable Hydrogels, Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of Tiscover in venous leg ulcer (VLU). Started Aug 2012; status: terminated.

02

Drugs

Tiscover
03

Conditions

venous leg ulcer (VLU)

Beyond the preview

Go deeper on NCT02360358.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02360358.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call